Boston Scientific Deep Brain Stimulation’s Post

Deep Brain Stimulation (DBS) can vastly improve the quality of life for patients with movement disorders like Parkinson’s disease, but is currently underutilised. Hear from Francesca Morgante, consultant neurologist, professor of Neurology, and the Eleanor Peel Chair for the study of Aging at St George’s University of London, and Vincent Sourdaine, Vice President of Neuromodulation, EMEA, at Boston Scientific, about the status of Parkinson’s Disease and its treatments. By examining the full procedure and how it can be optimised to accelerate planning and programming, time can be freed for both physician and patient. https://lnkd.in/dMAR3-5H #BSCEMEA

Parkinson’s DBS treatment vastly underutilized in the UK

Parkinson’s DBS treatment vastly underutilized in the UK

bostonsci.co

To view or add a comment, sign in

Explore topics